P070 ‘ChemSex’ within men who have sex with men (MSM): How big is the problem outside major conurbations?: Abstract P070 Table 1

Wiggins, H. V.; Mebrahtu, Helen; Sullivan, Ann; Field, Nigel; Hughes, Gwenda

doi:10.1136/sextrans-2016-052718.124

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…London appeared to be the focus for data collection, with seven studies reporting exclusively London data and five recruiting from London alongside other urban centres. Data suggest Chemsex is more prevalent in London, Manchester and Brighton (Schmidt et al, 2016), however anecdotal reports and recent evidence suggesting use of drugs associated Chemsex is common across the UK, has resulted in calls for a targeted sexual health response across the UK (Moncrief, 2014;Wiggins, Mebrahtu, Sullivan, Field, & Hughes, 2016).…”

Section: Injection Of Chemsex Drugsmentioning

confidence: 99%

Sexualised drug use in the United Kingdom (UK): A review of the literature

Edmundson

Heinsbroek

Glass

et al. 2018

International Journal of Drug Policy

167

135

View full text Add to dashboard Cite

show abstract

Section: Injection Of Chemsex Drugsmentioning

confidence: 99%

Sexualised drug use in the United Kingdom (UK): A review of the literature

Edmundson

Heinsbroek

Glass

et al. 2018

International Journal of Drug Policy

167

135

View full text Add to dashboard Cite

show abstract

“…A recent study confirms that chemsex drugs are frequently used by MSM in Amsterdam [17]. It is likely that chemsex might also be prevalent outside major cities [22]. However, limited epidemiological data on chemsex and the specific drugs used during sex is available outside major cities.…”

Section: Introductionmentioning

confidence: 99%

Chemsex among men who have sex with men living outside major cities and associations with sexually transmitted infections: A cross-sectional study in the Netherlands

et al. 2019

View full text Add to dashboard Cite

Background The intentional use of drugs to have sex–chemsex–among men who have sex with men (MSM) might contribute to the high sexually transmitted infections (STI) prevalence in this group. Limited data is available on chemsex outside major cities. The current study investigated the use of a wide variety of drugs during sex among MSM living outside major cities in the Netherlands and their associations with STI. Methods In 2018, 350 MSM were recruited at STI clinics and 250 MSM completed an online questionnaire. Questionnaire data were linked to clients’ most recent STI laboratory test results. Chemsex was defined as using cocaine, crystal meth, designer drugs, GHB/GBL, ketamine, speed, or XTC/MDMA during sex in the preceding six months. The use of other drugs was also assessed. Determinants (chemsex, specific drugs, number of drugs, combining, and frequency) potentially associated with STI were assessed using multivariable logistic regression analyses adjusting for sociodemographic characteristics and sexual history. Results Chemsex was reported by 35% (95%CI: 29–41) of the 250 participants. XTC/MDMA (27%; 68/250) and GHB/GBL (26%; 64/250) were the most used drugs. STI positivity was 33% (29/87) in MSM engaging in chemsex and 12% (12/163) in MSM not engaging in chemsex (p<0.001). Half of MSM engaging in chemsex (45/87) used three of more different chemsex drugs; STI positivity in this group was 44% (20/45). The only factor independently associated with STI was the use of three or more chemsex drugs (aOR: 4.13, 95%CI: 1.77–9.62). Conclusion This study shows that chemsex is prevalent among MSM visiting the STI clinic outside major cities in the Netherlands, suggesting that health services in both urban and non-urban areas should be aware of and informed on chemsex. MSM who used multiple drugs are at particular risk for STI, indicating a special need for STI prevention and care in this group.

show abstract

“…The interest is mainly driven by the strong associations with high-risk sexual behaviour 5 17 and other potential harms such as overdose and death. 18 Data from some sexual health clinics suggest there has been a rapid rise in chemsex drug use by MSM attending STI clinics within the last few years, 9 19 both in and out of major conurbations, 20 and chemsex has become a considerable public health concern. Public Health England’s 2015/2016 action plan to promote the health and well-being of MSM 2 and the UK government 2017 Drug Strategy 21 both target chemsex and aim to reduce it; however, current evidence on prevalence of chemsex drug use is limited, as is the impact chemsex drug use may have on sexual behaviour.…”

Section: Introductionmentioning

confidence: 99%

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–2016

Sewell

Cambiano²,

Miltz³

et al. 2018

Sex Transm Infect

View full text Add to dashboard Cite

ObjectivesThe objective of this study was to compare the prevalence of polydrug use, use of drugs associated with chemsex, specific drug use, and HIV-related behaviours, between two time periods, using two groups of HIV-negative men who have sex with men (MSM) attending the same sexual health clinics in London and Brighton, in two consecutive periods of time from 2013 to 2016.MethodsData from MSM in the cross-sectional Attitudes to and Understanding Risk of Acquisition of HIV (AURAH) study (June 2013 to September 2014) were compared with baseline data from different MSM in the prospective cohort study Attitudes to and Understanding Risk of Acquisition of HIV over Time (AURAH2) (November 2014 to April 2016). Prevalence of polydrug use, drug use associated with chemsex and specific drug use, and 10 measures of HIV-related behaviours including condomless sex, post-exposure prophylaxis (PEP) use, pre-exposure prophylaxis (PrEP) use, and HIV testing, were compared. Prevalence ratios (PRs) for the association of the study (time period) with drug use and HIV-related behaviour measures were estimated using modified Poisson regression analysis, unadjusted and adjusted for sociodemographic factors.ResultsIn total, 991 MSM were included from AURAH and 1031 MSM from AURAH2. After adjustment for sociodemographic factors, use of drugs associated with chemsex had increased (adjusted PR (aPR) 1.30, 95% CI 1.11 to 1.53) and there were prominent increases in specific drug use; in particular, mephedrone (aPR 1.32, 95% CI 1.10 to 1.57), γ-hydroxybutyric/γ-butryolactone (aPR 1.47, 95% CI 1.15 to 1.87) and methamphetamine (aPR 1.42, 95% CI 1.01 to 2.01). Use of ketamine had decreased (aPR 0.54, 95% CI 0.38 to 0.78). Certain measures of HIV-related behaviours had also increased, most notably PEP use (aPR 1.50, 95% CI 1.21 to 1.88) and number of self-reported bacterial STI diagnoses (aPR 1.24, 95% CI 1.08 to 1.43).ConclusionsThere have been significant increases in drug use associated with chemsex and some measures of HIV-related behaviours among HIV-negative MSM in the last few years. Changing patterns of drug use and associated behaviours should be monitored to enable sexual health services to plan for the increasingly complex needs of some clients.

show abstract

P070 ‘ChemSex’ within men who have sex with men (MSM): How big is the problem outside major conurbations?: Abstract P070 Table 1

Cited by 4 publications

References 0 publications

Sexualised drug use in the United Kingdom (UK): A review of the literature

Sexualised drug use in the United Kingdom (UK): A review of the literature

Chemsex among men who have sex with men living outside major cities and associations with sexually transmitted infections: A cross-sectional study in the Netherlands

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013–2016

Contact Info

Product

Resources

About